Short-term Supplementation, Bone Turnover and Antioxidant Status in Menopause
Short-term Supplementation, Bone Turnover and Antioxidant Status in Menopause
NCT ID: NCT03672513 Phase: NA Status: COMPLETED Enrollment: 78 Completion: 2018-09-08
Conditions
Menopause, Nutritional Intervention, Bone Diseases
Interventions
Placebo Comparator, Zinc Supplement, Magnesium supplement
Summary
This is a 8-week, double-blinded, placebo-controlled, randomized intervention trial to investigate the effects of Mg and Zn supplementation on antioxidant status and bone hormonal parameters. Participants were randomly assigned to one of three treatment groups: Placebo group (PbG: 25 women); Magnesium Group - 500 mg/day of Mg (MgG: 27 women); Zinc Group - 50 mg/day of Zn (ZnG: 26 women).
Primary Outcome
Antioxidant status